Autopsy report · NCT00131612

An Investigation of the Effect of the Promoter Polymorphism in the Glucuronosyltransferase 2B7 in Patients on Breast Cancer Treatment

Cause of deathOther Automatic label, confidence 0.3, unverified. How labels are made.

“did not apply for ethics renewal”

The sponsor’s own words in the registry.

Life of this trial

Registered 3 years 7 months after it had already started.
Ran for about 11 years before it stopped.
120 participants enrolled.
No results are posted on the registry.

Vital statistics

Status: Terminated
Sponsor: AHS Cancer Control Alberta
Sponsor type: University, hospital or other
Conditions: Breast Cancer
Interventions: FEC 100
Participants: 120
Sites: 1
Countries: Canada

Look deeper

The official registry record (the source of truth)
Record history: every change the sponsor made
Open it in the database

Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.